Filing Details

Accession Number:
0001209191-19-057766
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-22 15:34:37
Reporting Period:
2019-11-21
Accepted Time:
2019-11-22 15:34:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1668243 Urogen Pharma Ltd. URGN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1764157 A. Elizabeth Barrett C/o Urogen Pharma Ltd.
499 Park Avenue
New York City NY 10022
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-11-21 7,530 $28.00 16,548 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct